Skip to content

Clinical trials

Dementia trials in Singapore

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Dementia Country / region: Singapore Clear all

24 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20121
20131
20142
20153
20172
20191
20212
20221
20231
20241
20253
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Recruiting5
Unknown status5
Not yet recruiting2
Active, not recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National University of Singapore7
Duke-NUS Graduate Medical School4
National University Hospital, Singapore2
TauRx Therapeutics Ltd2
Alexandra Hospital1
Axovant Sciences Ltd.1
Bristol-Myers Squibb1
Changi General Hospital1
Eli Lilly and Company1
Institute of Mental Health, Singapore1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Dementia24
Cognitive Dysfunction12
Alzheimer Disease9
Brain Diseases4
Neurodegenerative Diseases4
Brain Injuries, Traumatic1
Central Nervous System Diseases1
Cognition Disorders1
Delirium1
Diabetes Mellitus, Type 21

Trials

Showing 1 to 24 of 24. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.